How will immune tolerance protocols affect self-sufficiency goals?
作者信息
Brackmann H H
机构信息
Haemophilia Centre, University of Bonn, Germany.
出版信息
Blood Coagul Fibrinolysis. 1994 Dec;5 Suppl 4:S77-9. doi: 10.1097/00001721-199412004-00020.
Abstract
Inhibitor development is a serious complication in haemophilia, and its treatment, immune tolerance therapy, is an expensive part of haemophilia treatment. However, the therapy can lead to an increased lifespan and improved quality of life. If commenced sufficiently early in the disease, it can help to reduce the overall amount of factor VIII concentrate, or other plasma derived therapeutic agents required during life.
摘要
Zotero 插件